Skip to main content
OpenTrials
Completed

NCT Number: NCT00318305

Patient Preference With Visicol Tablet Preparation for Colonoscopy

The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonoscopy. This study will provide answers related to the patient preferences and their acceptance of this new method of bowel preparation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic

Scottsdale, Arizona, 85259, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prior colonoscopy with PEG solution in the past one year
  • Must be able to swallow tablets

Exclusion criteria

  • Patients below 18 years and above 100 years.
  • Congestive heart failure
  • Chronic renal failure
  • Pre-existing electrolyte disorder
  • Pre-existing mega-colon or a motility disorder.
  • Patients with pre-existing seizure disorder.
  • Patients scheduled for colonoscopy after 1:00 p.m. will be excluded from the study.
  • Pregnant or lactating women

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • InKine Pharmaceutical

Registry information

Official study title

Patient Preference and Acceptance With Sodium Phosphate Tablet Preparation for Colonoscopy: A Prospective Study

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Apr 26, 2006
Registry last updated
Dec 2, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.